Interventional Oncology vs. Liver Tumors: Whats in the quiver? Howard M. Richard, III, MD.
Intellectual Property Protection for Drugs, Biologics and Medical Devices in the U.S. and European Union Comparative EU and U.S. Science, Law and Policy.
House Officers Guide To Renal Patients Staci Smith, DO.
Prevalence and Patterns of Nonmedical Use of OxyContin ® and Other Pain Relievers Joe Gfroerer Office of Applied Studies Substance Abuse and Mental Health.
Equivalence Tests in Clinical Trials Chunqin Deng, PhD PPD Development Research Triangle Park, NC 27560.
Whats All the Rave About?. Overview What is ecstasy? What are ecstasys effects and signs of use? Who uses ecstasy? What are the treatment options? What.
Pharmacology: Studying the principles of Drug Action Pharmacokinetics Pharmacodynamics: Drug action Two ways to measure drug effects: Psychopharmacologylook.
1. 2 ACEI inhibit angiotensin converting enzyme in the body. ACEI inhibit angiotensin converting enzyme in the body. Enzyme maintains balance between:
Chemotherapy. Assumption of the Biological Approach The biological approach is interested in how behaviour is influenced by chemical imbalances in the.
Improving FDAs approach to new drug approval and post-marketing surveillance Jerry Avorn, M.D. Professor of Medicine, Harvard Medical School Chief, Division.
Regulatory Perspectives on the Thorough QT/QTc Study 2005 FDA/Industry Workshop Washington DC September 16, 2005 Juan (Joanne) Zhang, Ph.D. CDER/FDA *Acknowledgement:
Gatekeeping Testing Strategies in Clinical Trials Alex Dmitrienko, Ph.D. Eli Lilly and Company FDA/Industry Statistics Workshop September 2004.